Galmed Pharmaceuticals
GLMD
$0.39
Share price
0.90%
Change (1 day)
30.53%
Change (1 year)
Categories
Galmed Pharmaceuticals (GLMD) - Cash on Hand
Cash on Hand as of September 2023 : $13.31 M
According to Galmed Pharmaceuticals
's latest financial reports the company has $13.31 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Galmed Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $13.78 M | -60.4% |
| 2021-12-31 | $34.81 M | -31.58% |
| 2020-12-31 | $50.88 M | -32.59% |
| 2019-12-31 | $75.49 M | -16.3% |
| 2018-12-31 | $90.18 M | 374.75% |
| 2017-12-31 | $18.99 M | 22.97% |
| 2016-12-31 | $15.44 M | -32.84% |
| 2015-12-31 | $23 M | -28.09% |
| 2014-12-31 | $31.98 M | 23247.45% |
| 2013-12-31 | $0.13 M | -80.92% |
| 2012-12-31 | $0.71 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | $4.73 M | -64.40% | 🇺🇸 USA |
 Endo International
ENDPQ | $0.77 B | 5,743.30% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.17 B | 1,195.46% | 🇺🇸 USA |
 Catalent CTLT | $0.22 B | 1,620.12% | 🇺🇸 USA |